RU94007001A - SALTS 2-MORFOLIN-5-PHENYL-6N-1,3,4-TIADIAZINE AND 4,7-DIGIDRO-6-NITRO-7-OXO- / 1,2,4 / -TRIAZOLO / 5,1-С // 1,2,4 / -TRIAZINES, possessing bacterial activity with respect to mycoplasmosis agent - Google Patents

SALTS 2-MORFOLIN-5-PHENYL-6N-1,3,4-TIADIAZINE AND 4,7-DIGIDRO-6-NITRO-7-OXO- / 1,2,4 / -TRIAZOLO / 5,1-С // 1,2,4 / -TRIAZINES, possessing bacterial activity with respect to mycoplasmosis agent

Info

Publication number
RU94007001A
RU94007001A RU94007001/04A RU94007001A RU94007001A RU 94007001 A RU94007001 A RU 94007001A RU 94007001/04 A RU94007001/04 A RU 94007001/04A RU 94007001 A RU94007001 A RU 94007001A RU 94007001 A RU94007001 A RU 94007001A
Authority
RU
Russia
Prior art keywords
mycoplasmosis
triazolo
triazines
oxo
nitro
Prior art date
Application number
RU94007001/04A
Other languages
Russian (ru)
Other versions
RU2058307C1 (en
Inventor
В.Л. Русанов
Л.П. Сидорова
Т.Л. Пиличева
О.Н. Чупахин
Original Assignee
МТД "Лиганд"
Filing date
Publication date
Application filed by МТД "Лиганд" filed Critical МТД "Лиганд"
Priority to RU94007001A priority Critical patent/RU2058307C1/en
Priority claimed from RU94007001A external-priority patent/RU2058307C1/en
Publication of RU94007001A publication Critical patent/RU94007001A/en
Application granted granted Critical
Publication of RU2058307C1 publication Critical patent/RU2058307C1/en

Links

Claims (1)

Соли 2-морфолино-5-фенил-6H-1,3,4-тиадиазина и 4,7-дигидро-6-нитро-7-оксо-[1,2,4] -триазоло[5,1-с][1,2,4]- триазинов обладают бактерицидной активностью в отношении возбудителя микоплазмоза, относится к новым биологическим активным соединениям. Соединения могут быть использованы для создания лекарственных препаратов против устойчивых бактерий микоплазмы.Salts of 2-morpholino-5-phenyl-6H-1,3,4-thiadiazine and 4,7-dihydro-6-nitro-7-oxo- [1,2,4] -triazolo [5,1-s] [ 1,2,4] - triazines possess bactericidal activity against the pathogen mycoplasmosis, refers to a new biological active compounds. The compounds can be used to create drugs against resistant mycoplasma bacteria.
RU94007001A 1994-03-01 1994-03-01 Salts of 2-morpholino-5-phenyl-6h-1,3,4-thiadiazine and 4,7-dihydro-6-nitro-7-oxo-[1,2,4]-triazolo[5,1-c][1,2,4]-triazines having bactericidal activity in relation to inducer of micoplasmosis RU2058307C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94007001A RU2058307C1 (en) 1994-03-01 1994-03-01 Salts of 2-morpholino-5-phenyl-6h-1,3,4-thiadiazine and 4,7-dihydro-6-nitro-7-oxo-[1,2,4]-triazolo[5,1-c][1,2,4]-triazines having bactericidal activity in relation to inducer of micoplasmosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94007001A RU2058307C1 (en) 1994-03-01 1994-03-01 Salts of 2-morpholino-5-phenyl-6h-1,3,4-thiadiazine and 4,7-dihydro-6-nitro-7-oxo-[1,2,4]-triazolo[5,1-c][1,2,4]-triazines having bactericidal activity in relation to inducer of micoplasmosis

Publications (2)

Publication Number Publication Date
RU94007001A true RU94007001A (en) 1995-12-20
RU2058307C1 RU2058307C1 (en) 1996-04-20

Family

ID=20153003

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94007001A RU2058307C1 (en) 1994-03-01 1994-03-01 Salts of 2-morpholino-5-phenyl-6h-1,3,4-thiadiazine and 4,7-dihydro-6-nitro-7-oxo-[1,2,4]-triazolo[5,1-c][1,2,4]-triazines having bactericidal activity in relation to inducer of micoplasmosis

Country Status (1)

Country Link
RU (1) RU2058307C1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028068A (en) * 1995-12-28 2000-02-22 The Procter & Gamble Company Substituted 6H-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
US6313111B1 (en) 1995-12-28 2001-11-06 The Procter & Gamble Company Substituted 6H-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and pharmaceutical composition containing them

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2493158C2 (en) * 2009-11-24 2013-09-20 Российская Федерация, От Имени Которой Выступает Министерство Образования И Науки Российской Федерации SODIUM SALT OF 2-METHYL-6-FLUORO-1,2,4-TRIAZOLO[5,1-c]-1,2,4-TRIAZIN-7(4H)-ONE DIHYDRATE, HAVING ANTIVIRAL ACTIVITY
RU2536874C1 (en) * 2013-11-01 2014-12-27 Общество с ограниченной ответственностью "Уральский центр биофармацевтических технологий 2-METHYLSULPHANYL-6-NITRO-OXO-1,2,4-TRIAZOLO[5,1-c] [1,2,4]TRIAZINIDE L-ARGININIUM DIHYDRATE, POSSESSING ANTIVIRAL ACTIVITY, METHOD OF ITS OBTAINING AND APPLICATION FOR PREVENTION AND TREATMENT OF WEST NILE FEVER

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028068A (en) * 1995-12-28 2000-02-22 The Procter & Gamble Company Substituted 6H-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
US6313111B1 (en) 1995-12-28 2001-11-06 The Procter & Gamble Company Substituted 6H-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and pharmaceutical composition containing them

Similar Documents

Publication Publication Date Title
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
CA2183972A1 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
CA2378424A1 (en) Moxifloxacin formulation containing common salt
HUP9904308A3 (en) Use of mupirocin for manufacture of a medicament for the treatment of bacterial infections associated with colonisation by pathogenic organisms at the nasopharynx
DE3679920D1 (en) SPIRO-3-HETEROAZOLIDINE COMPOUNDS AND THEIR SALTS, THEIR PRODUCTION AND THE PHARMACEUTICAL AGENTS CONTAINING THEM.
IT8919413A0 (en) COMPOSITION HAVING BACTERICIDAL OR BACTERIOSTATIC ACTIVITY.
DE69631609D1 (en) Tricyclische erythromycinderivate
BR0012253A (en) 1-methylcarbapenem derivative, pharmaceutical composition for the prevention or treatment of bacterial infections, use of a crystalline form of 1-methylcarbapenem derivative, and method for the prevention or treatment of bacterial infections
ATE141605T1 (en) THIENOTRIAZOLDIAZEPINE COMPOUNDS AND THEIR PHARMACEUTICAL USES
EP0342587A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
CA2380455A1 (en) 9a-azalides with antibacterial activity
RU94007001A (en) SALTS 2-MORFOLIN-5-PHENYL-6N-1,3,4-TIADIAZINE AND 4,7-DIGIDRO-6-NITRO-7-OXO- / 1,2,4 / -TRIAZOLO / 5,1-С // 1,2,4 / -TRIAZINES, possessing bacterial activity with respect to mycoplasmosis agent
BG101570A (en) Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity
CA2037779A1 (en) Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t
ITRM940388A0 (en) "CLEANSING WATER COMPOSITION, WITH ANTIBACTERIAL ACTIVITY, FOR THE SKIN".
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
IL108651A0 (en) 3-isothiazolones, their preparation and their use as antimicrobial agents
IT8421241A0 (en) COMPOUNDS WITH ANTIBACTERIAL ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
CA2248794A1 (en) Medicament for preventive and treatment for viral infectious diseases
CA2281133A1 (en) Multiple-agents-binding compound and use thereof
IT8821731A0 (en) KIT FOR THE REACTIVATION OF DRIED MICROBIAL CULTURES, IN PARTICULAR BACTERIA.
RU97101062A (en) APPLICATION OF SALTS OF POLYHEXAMETHYLENE GUANIDINIA AS DRUGS WITH ANTIMICROBIC ACTIVITY WITH RESPECT TO ANAEROBIC AND MIXED INFECTION
CA2057456A1 (en) Anti depression pharmaceutical
IT8125298A0 (en) COMPOUND WITH ANTI-INFLAMMATORY, DISINFECTANT AND ANTIBACTERIAL ACTIVITY, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.